[{"indications": "Indications\u00a0 advanced prostate cancer, see also notes above", "name": "FLUTAMIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "8 Malignant disease and immunosuppression", "8.3 Sex hormones and hormone antagonists in malignant disease", "8.3.4 Hormone antagonists", "8.3.4.2 Gonadorelin analogues and gonadotrophin-releasing hormone antagonists", "Anti-androgens"], "cautions": "Cautions\u00a0cardiac disease (oedema\r\nreported); also liver function tests, monthly for first\r\n4 months, periodically thereafter and at the first sign\r\nor symptom of liver disorder (e.g. pruritus, dark urine, persistent\r\nanorexia, jaundice, abdominal pain, unexplained influenza-like symptoms); avoid excessive alcohol consumption; avoid in acute porphyria (section 9.8.2); interactions: Appendix 1 (flutamide)", "side-effects": "Side-effects\u00a0gynaecomastia (sometimes with galactorrhoea);\r\nnausea, vomiting, diarrhoea, increased appetite, insomnia, tiredness;\r\nother side-effects reported include decreased libido, reduced sperm\r\ncount, gastric and chest pain, hypertension, headache, dizziness,\r\noedema, blurred vision, thirst, rash, pruritus, haemolytic anaemia,\r\nsystemic lupus erythematosus-like syndrome, and lymphoedema; hepatic\r\ninjury (with transaminase abnormalities, cholestatic jaundice, hepatic\r\nnecrosis, hepatic encephalopathy and occasional fatality) reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4828.htm", "doses": ["250\u00a0mg 3 times daily (see also notes above)"]}]